Global Vitamin Biomarkers Market to Reach USD 9.8 Billion by 2033, Driven by Rising Awareness, Advancements in Technology, and Growing Demand for Preventive Healthcare | FMI

In 2023, the vitamin biomarkers market is expected to be worth USD 3.2 billion. The market is expected to reach USD 9.8 billion by 2033, expanding at an 11.9% CAGR throughout the forecast period. The vitamin biomarkers market has experienced significant growth in recent years due to increasing awareness about the importance of vitamins in maintaining health, rising prevalence of vitamin deficiencies and related diseases, advancements in diagnostic technologies, growing interest in personalized nutrition, and the aging population with a higher demand for preventive healthcare.

The vitamin biomarkers market is witnessing several emerging trends. These include the integration of digital health solutions for real-time monitoring and personalized recommendations, advancements in genetic testing and nutrigenomics, the development of novel biomarkers for specific vitamins, and expansion into emerging markets with a focus on addressing nutritional deficiencies.

With the rising prevalence of chronic diseases and a shift toward preventive healthcare, there is an increasing emphasis on identifying nutritional deficiencies early on. Vitamin biomarkers can aid in early detection and intervention, supporting preventive healthcare strategies.

The growing interest in personalized nutrition and individualized healthcare is driving the demand for accurate assessment of vitamin status. Consumers are seeking customized dietary recommendations based on their specific nutritional needs, and biomarkers play a crucial role in providing personalized insights.

Key Takeaways from the Vitamin Biomarkers Market:

  • The vitamin biomarkers industry in the United States is predicted to reach USD 2.3 billion by 2033, increasing at a 12.4% CAGR.
  • The vitamin biomarkers industry in the United Kingdom is estimated to reach a market value of USD 303.1 million, expanding at a CAGR of 8.9% by 2033.
  • During the forecast period, the vitamin biomarkers industry in China is expected to reach a market value of USD 902.4 million, securing an 14.6% CAGR.
  • The vitamin biomarkers industry in Japan is predicted to reach USD 612.8 million by 2033, increasing at a 14.0% CAGR.
  • During the forecast period, the vitamin biomarkers industry in South Korea is expected to reach a market value of USD 291.9 million, securing an 12.9% CAGR.
  • With a CAGR of 12.3% from 2023 to 2033, Analyzers is expected to dominate the vitamin biomarkers industry.
  • With a CAGR of 13.8% from 2023 to 2033, the Serum 25(OH)D (Vitamin D) is expected to dominate the vitamin biomarkers industry.
  • With a CAGR of 10.8% from 2023 to 2033, the Enzyme-Linked Immunosorbent Assay (ELISA) is expected to dominate the vitamin biomarkers industry.
  • With a CAGR of 13.3% from 2023 to 2033, the diagnostic laboratories is expected to dominate the vitamin biomarkers industry.

Elevated Market Interest: Delve into In-Depth Trends and Insights with Our Full Report!

How Does the Competition Look in the Vitamin Biomarkers Market?

The vitamin biomarkers sector is a very competitive one, with many firms fighting for market share. Several significant participants in this industry comprise DiaSorin, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, Randox Laboratories, PerkinElmer, Merck KGaA, BioMérieux & Shimadzu Corporation.

The major companies are spending in research & development efforts to create innovative and inventive care with enhanced effectiveness, dependability, and affordability. They are also focusing on expanding their products related to vitamin biomarkers and strengthening their distribution methods in order to fulfil shifting consumer expectations.

Tactical alliances and partnerships with other companies are becoming more common in the industry, allowing parties to leverage one another’s strengths and expand their market influence.

Leading firms use consolidation and mergers to strengthen their market position and gain entry into new markets. The sector is expanding significantly in developing economies, particularly in India and China.

To boost their presence in these regions, major companies are expanding their distribution networks and building regional manufacturing sites. They are also concentrating on offering cost-effective products to customers in these markets in order to get a competitive advantage.

Recent Developments in the Vitamin Biomarkers Market:

  • In August 2022, Thermo Fisher Scientific Inc. announced plans to expand its local medical device assembly facility, investing $40 million and creating over 100 new jobs in the region.
  • In May 2022, Shimadzu Corporation proposed acquiring a 45.9% stake in Nissui Pharmaceutical Co., Ltd. for approximately $16.6 billion.

Segmentation Analysis of the Vitamin biomarkers Market:

By Product:

  • Analyzers
  • Test Kits
  • Reagents & Consumables

By Biomarker Type:

  • Serum Retinol (Vitamin A)
  • Ascorbic Acid (Vitamin C)
  • Serum 25(OH)D (Vitamin D)
  • Serum Alpha-tocopherol (Vitamin E)
  • Serum Prothrombin (Vitamin K)
  • Serum Thiamine Diphosphate (Vitamin B1)
  • Serum Glycolate (Vitamin B2)
  • Serum Niacin (Vitamin B3)
  • Serum Plasma PLP (Vitamin B6)
  • Serum Vitamin B12
  • Serum Folate (Vitamin B9)
  • Other Biomarkers

By Testing Method:

  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Liquid Chromatography with tandem mass spectrometry (LC-MS-MS)
  • High-performance liquid chromatography (HPLC)
  • Chemiluminescent Immunoassay (CLIA)

By End User:

  • Hospitals
  • Diagnostic Laboratories
  • Ambulatory Diagnostic Centers
  • Homecare Settings

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *